Zimmer Biomet Holdings Inc (NYSE: ZBH) is 2.00% higher on its value in year-to-date trading and has touched a low of $102.00 and a high of $149.25 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The ZBH stock was last observed hovering at around $126.37 in the last trading session, with the day’s loss setting it -2.24%.
Currently trading at $124.13, the stock is -1.18% and 0.89% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.42 million and changing -1.77% at the moment leaves the stock 0.78% off its SMA200. ZBH registered 0.67% gain for a year compared to 6-month gain of 5.62%. The firm has a 50-day simple moving average (SMA 50) of $4.19 and a 200-day simple moving average (SMA200) of $13.94.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 0.98% loss in the last 1 month and extending the period to 3 months gives it a 9.04%, and is -3.29% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.44% over the week and 2.12% over the month.
Zimmer Biomet Holdings Inc (ZBH) has around 18000 employees, a market worth around $25.46B and $7.39B in sales. Current P/E ratio is 25.39 and Fwd P/E is 14.27. Profit margin for the company is 13.85%. Distance from 52-week low is 21.70% and -16.83% from its 52-week high. The company has generated returns on investments over the last 12 months (5.84%).
Zimmer Biomet Holdings Inc quarterly earnings per share for the current quarter are estimated at $1.88 with sales reaching $1.87B over the same period.The EPS is expected to grow by 6.80% this year, but quarterly earnings will post 4.90% year-over-year. Quarterly sales are estimated to grow 9.80% in year-over-year returns.
1,408 institutions hold shares in Zimmer Biomet Holdings Inc (ZBH), with institutional investors hold 91.21% of the company’s shares. The shares outstanding are 205.60M, and float is at 204.86M with Short Float at 2.04%. Institutions hold 91.11% of the Float.
The top institutional shareholder in the company is Vanguard Group Inc with over 24.13 million shares valued at $3.51 billion. The investor’s holdings represent 11.55% of the ZBH Shares outstanding. As of Jun 29, 2023, the second largest holder is Blackrock Inc. with 22.1 million shares valued at $3.22 billion to account for 10.58% of the shares outstanding. The other top investors are Price (T.Rowe) Associates Inc which holds 9.22 million shares representing 4.41% and valued at over $1.34 billion, while State Street Corporation holds 4.33% of the shares totaling 9.06 million with a market value of $1.32 billion.
Zimmer Biomet Holdings Inc (ZBH) Insider Activity
A total of 2 insider transactions have happened at Zimmer Biomet Holdings Inc (ZBH) in the last six months, with sales accounting for 0 and purchases happening 2 times. The most recent transaction is an insider sale by Phipps Chad F, the company’s Sr. VP/Gen Counsel/Secretary. SEC filings show that Phipps Chad F sold 26,156 shares of the company’s common stock on Feb 22 at a price of $128.62 per share for a total of $3.36 million. Following the sale, the insider now owns 44145.0 shares.
Zimmer Biomet Holdings Inc disclosed in a document filed with the SEC on Nov 09 that Jafry Syed A. (Director) bought a total of 2,135 shares of the company’s common stock. The trade occurred on Nov 09 and was made at $104.75 per share for $0.22 million. Following the transaction, the insider now directly holds 4060.0 shares of the ZBH stock.
Still, SEC filings show that on Aug 30, Kolli Sreelakshmi (Director) acquired 1,000 shares at an average price of $120.37 for $0.12 million. The insider now directly holds 1,000 shares of Zimmer Biomet Holdings Inc (ZBH).
Zimmer Biomet Holdings Inc (ZBH): Who are the competitors?
One of the company’s main competitors (and peers) include Johnson & Johnson (JNJ) that is trading 5.89% up over the past 12 months.Medtronic PLC (MDT) lies in the list of competitors of the Zimmer Biomet Holdings Inc and is 1.56% higher over the same period from ZBHStryker Corp. (SYK) is 35.32% up on the 1-year trading charts.
